News

June 2, 2025. More for You ...
The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the presentation of the uTRACT Registry ...